Close integration with St George’s Hospital, clinicians and public health physicians ensures that our research is of clinical value.
Working with St George's Hospital
We undertake a wide range of studies focused on clinical application in diagnostics, therapeutics and vaccinology. We lead and contribute to national and international trials to improve anti-infective drugs and how they are used.
Sharing the same site in south west London, our institute and St George’s Hospital work closely together to ensure that our research addresses important health challenges, and that new knowledge and technologies generated by research are quickly applied in clinical settings.
Our clinical facilities
We have access to the specialist adult and paediatric infection units at St George's Hospital. These are run by clinical academics based in the institute. The paediatric unit is an infectious disease referral centre and a UK centre of excellence in the treatment of complex infections in children. Both units incorporate purpose-built specialist infectious disease wards, with negative-pressure rooms for containment isolation. We diagnose and treat a diverse range of infections from all over the world, reflecting the internationally diverse community we serve.
We are closely integrated with all clinical infection services at St George’s Hospital, including the South West London Pathology Hub. This gives our researchers access to more than a million clinical samples each year.
We have strong ties with other clinical specialties, such as oncology, respiratory medicine and genito-urinary medicine. As well as providing new insight into infections in patients with underlying health conditions, we can explore the immunological basis of disease in these areas. This provides an avenue for our research to impact on novel treatments, for example in developing innovative cancer treatments.
We carry out many clinical trials in paediatric and adult patients. A key resource for clinical translation of our research is St George’s Vaccine Institute – a specialist academic-led facility, specifically focusing on phase I–III clinical trials of paediatric and adult vaccines.